Physician profile
David M Rutenberg
NPI 1073045662
$1,016.52
in general payments reported to CMS, 2019-2025
12 companies · $95.70 in 2025
The $95.70 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $23.37 · 2021: $360 · 2022: $249 · 2023: $17.98 · 2024: $72.38 · 2025: $95.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $124.95 | 2022 | |
| Astellas Pharma US INC | $123.84 | 2022 | |
| Exelixis INC. | $122.51 | 2021 | |
| Alexion Pharmaceuticals, INC. | $120.04 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $117.02 | 2021 | |
| Genentech USA, INC. | $115.36 | 2019 | |
| Adc Therapeutics America, INC. | $95.70 | 2025 | |
| United Therapeutics Corporation | $83.37 | 2019 | |
| Janssen Scientific Affairs, LLC | $59.28 | 2024 | Talvey, Tecvayli, Darzalex |
| Takeda Pharmaceuticals U.S.A., INC. | $23.37 | 2020 | |
| Csl Behring | $17.98 | 2023 | Kcentra |
| La Jolla Pharmaceutical Company | $13.10 | 2024 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rutenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.